MERIT MEDICAL SYSTEMS INC
For the period ended May 13, 2026. Filed Mar 31, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 13, 2026 · Filed Mar 31, 2026
MMSI$87.23-2.7%Stored close · as of Nov 6, 2026
Contents
Director Whose Term of Office Does Not Continue
| 64June 2020 Governance (Chair), Finance NoneB.S., Grace College 2026 | |
|---|---|
| DAVID K. FLOYDIndependent DirectorAge: 65Director Since: June 2020Committees: Governance (Chair), FinanceOther Public Boards: NoneEducation: B.S., Grace CollegeTerm Expires: 2026 | |
| | |
| Career Highlights●Board Chair, Corin Group LTD, a privately-held global orthopedic enabling technology company, 2020 to January 2026●Board member and Operations Committee Chair of Health Outcomes Performance Company (HoPCo), a privately-owned musculoskeletal and value-based care company focused on transforming the patient care experience and improving the practice of medicine, 2020 to present●Senior Advisor, Permira, a leading global private equity investment firm, April 2023 to present●Group President, Orthopaedics, Stryker Corporation, 2012 to 2019●U.S. President and Worldwide President of Johnson & Johnson’s DePuy Orthopaedics, 2007 to 2011●Director, NN Inc., 2016 to 2020Service to MeritMr. Floyd brought more than 35 years of experience as a leader in the life sciences industry, including serving as president and CEO within several leading medical technology companies. Additionally, the Board believes Mr. Floyd’s general management experience of more than 20 years provided the Board with expertise on a broad range of matters, including mergers and acquisitions, strategic planning, global business and operations, corporate governance and product commercialization. The Board believes Mr. Floyd’s industry and management experience have been particularly beneficial through his service on the Governance, Finance and Operating Committees and his guidance in the Company’s development of our CGI Program. | |
| | |
12| Understand. Innovate. Deliver. TM
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.